| 69.04 1.6 (2.37%) | 05-05 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 83.41 | 1-year : | 97.43 |
| Resists | First : | 71.41 | Second : | 83.41 |
| Pivot price | 68.55 |
|||
| Supports | First : | 65.83 | Second : | 62.38 |
| MAs | MA(5) : | 67.39 |
MA(20) : | 68.09 |
| MA(100) : | 73.6  |
MA(250) : | 73.81 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 39.1 |
D(3) : | 33.7 |
| RSI | RSI(14): 54.6 |
|||
| 52-week | High : | 88.19 | Low : | 62.38 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ SOLV ] has closed below upper band by 39.6%. Bollinger Bands are 42% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 69.28 - 69.56 | 69.56 - 69.83 |
| Low: | 66.44 - 66.75 | 66.75 - 67.04 |
| Close: | 68.54 - 69.03 | 69.03 - 69.5 |
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Wed, 06 May 2026
Solventum gains after activist Trian sends letter urging changes (update) - MSN
Tue, 05 May 2026
Assessing Solventum (SOLV) Valuation After Recent Share Price Rebound And Product Pipeline Progress - simplywall.st
Tue, 05 May 2026
Solventum posts Q1 sales, adjusted EPS beats - MassDevice
Tue, 05 May 2026
Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Tue, 05 May 2026
Solventum (SOLV) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Tue, 05 May 2026
Profits slide as Solventum (NYSE: SOLV) faces tariffs, restructuring and weak cash flow - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 173 (M) |
| Shares Float | 147 (M) |
| Held by Insiders | 14.9 (%) |
| Held by Institutions | 73.7 (%) |
| Shares Short | 6,380 (K) |
| Shares Short P.Month | 3,970 (K) |
| EPS | 8.88 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 29.1 |
| Profit Margin | 18.6 % |
| Operating Margin | 7 % |
| Return on Assets (ttm) | 2.9 % |
| Return on Equity (ttm) | 38.8 % |
| Qtrly Rev. Growth | -3.8 % |
| Gross Profit (p.s.) | 25.71 |
| Sales Per Share | 48.03 |
| EBITDA (p.s.) | 6.74 |
| Qtrly Earnings Growth | 100.8 % |
| Operating Cash Flow | 369 (M) |
| Levered Free Cash Flow | 633 (M) |
| PE Ratio | 7.77 |
| PEG Ratio | 1.2 |
| Price to Book value | 2.37 |
| Price to Sales | 1.43 |
| Price to Cash Flow | 32.44 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|